Ivan Komaritsky
About Ivan Komaritsky
Ivan Komaritsky is an attorney with a Master of Laws from Columbia University Law School, specializing in white collar investigations, regulatory compliance, and commercial litigation. He has extensive experience in managing E-discovery, developing compliance programs, and advising on FCPA and sanctions compliance for multinational companies.
Work at Rimon PC
Ivan Komaritsky serves as an attorney at Rimon PC, where he focuses on white collar investigations, regulatory compliance, and commercial litigation. His role involves advising clients on complex legal matters, particularly related to the Foreign Corrupt Practices Act (FCPA), CFIUS, and US economic sanctions. He utilizes his extensive experience in managing E-discovery and conducting internal investigations to support multinational companies in navigating legal challenges.
Education and Expertise
Ivan Komaritsky holds a Master of Laws (LL.M.) from Columbia University Law School and a Juris Doctor (J.D.) from Moscow State University. His educational background provides him with a strong foundation in legal principles and practices. He is fluent in both English and Russian, which enhances his ability to serve a diverse clientele. His expertise includes developing compliance programs and conducting due diligence in various sectors, including financial services and digital payments.
Background
Ivan Komaritsky has over 12 years of experience working as an attorney at DLA Piper before joining Rimon PC. He is admitted to practice law in Russia, New York, and Connecticut. His professional journey includes significant involvement in managing E-discovery for multinational companies and conducting corporate due diligence in M&A transactions and project finance. He has worked on projects in various regions, including Russia, Eastern Europe, and the Middle East.
Achievements
Throughout his career, Ivan Komaritsky has developed and assessed FCPA and global anti-corruption compliance programs for multinational companies. He has represented a multinational pharmaceutical corporation in a Department of Justice investigation concerning potential FCPA violations. His work includes conducting internal investigations, FCPA corporate audits, and advising clients on sanctions compliance and list-based screenings for venture capital funds.